Home/Xeltis/Eliane Schutte
ES

Eliane Schutte

Chief Executive Officer

Xeltis

Xeltis Pipeline

DrugIndicationPhase
aXessVascular Access for HemodialysisPivotal/Pre-market
ETR-based GraftCoronary Artery Bypass Grafting (CABG)Pre-clinical/Clinical
ETR-based ValvePulmonary Valve ReplacementPre-clinical